Balyasny Asset Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Balyasny Asset Management's RGEN Position: Q2 2026 in Review
Balyasny Asset Management increased its Repligen (RGEN) stake by 183% in Q2 2026, buying an estimated $28.3M and bringing the position to 355,507 shares worth $48.5M. The position accounts for 0.06% of the portfolio, ranked #374.
Balyasny Asset Management first reported a position in RGEN in Q2 2018 and has held it in 21 quarters since. The position peaked at $103M in Q3 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Balyasny Asset Management held 355,507 shares of Repligen worth $48.5M as of Q2 2026.
- Balyasny Asset Management bought 230,038 Repligen shares in Q2 2026, an estimated $28.3M.
- Repligen made up 0.06% of Balyasny Asset Management's portfolio in Q2 2026, its #374 holding.
- Balyasny Asset Management first reported a position in Repligen in Q2 2018 and has held it in 21 quarters since.
- Balyasny Asset Management's Repligen position peaked at $103M in Q3 2025.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.